Digital Balancing global consistency and local nuance: EVERSANA on A... The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Sales & Marketing Optimising customer experience in global medical information... Technology and AI may come to bear in establishing global MI services.
Sales & Marketing Optimising customer experience in global medical information... In MI, it is increasingly important to find methodologies to increase global efficiencies while optimising the customer experience.
Market Access Part Two: Navigating the complexities of global market acces... The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.
Market Access Part One: Overcoming challenges and seizing opportunities in... The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked condi
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.